AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04725123 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Microbiome analysis
Description: Stool microbiome analysis of 16S rRNA sequencing to an anticipated number of 8,000,000 reads
Study NCT05383833 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine Monohydrate
Description: Participants will take 20 grams of creatine monohydrate daily for 8 weeks.The 20 grams will be divided into two equal 10 gram doses that will be stirred into a beverage. One 10 gram dose will be taken in the morning and the other 10 gram dose in evening.
Study NCT04691167 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive trans magnetic stimulation
Description: Repetitive Trans-cranial Magnetic Stimulation (rTMS) is a relatively safe and non-invasive method to modulate neuronal activity; rTMS uses alternating magnetic fields in a certain frequency to induce an electric current in the underlying brain tissue.
Study NCT04691167 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: repetitive trans magnetic stimulation
Description: Repetitive Trans-cranial Magnetic Stimulation (rTMS) is a relatively safe and non-invasive method to modulate neuronal activity; rTMS uses alternating magnetic fields in a certain frequency to induce an electric current in the underlying brain tissue.
Study NCT06545578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-level laser therapy
Description: The Low-level laser (LLL) pain-relief instrument RG-300IB (code E22), manufactured in China, was utilized for low-level laser therapy (LLLT) in Group A . The therapy employed a wavelength of 830 nm (near infrared) and involved careful skin contact hygiene at specified positions, 2.5 and 3.5 cm laterally from the spinous process (L4, L5, or S1) and one distal level segment. The laser operated at a repetition rate of 5,000, with a power density of 300 mW/cm2 and a power output of 10 mW. Each point received 3 J of energy, resulting in a density of 3 J/cm2, with four points. The spot size was 1 cm, and each point received a 30-second treatment. The energy was administered three times per week for four weeks
Study NCT06545578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TENS
Description: TENS Intelect Advanced device (Chattanooga, Mouguerre, France). The parameters for TENS stimulation included a frequency range of 60-80 Hz, a pulse width of 50-80 ms, and an intensity of 10-30 mA. Before commencing therapy, patients were provided information regarding the therapeutic approach and any potential adverse effects. During the procedure, two channels (four electrodes) were employed, with one set placed on the right and one on the left paraspinal muscles at the level of L2-L4. Active electrodes from the other channels were affixed 1.5 cm laterally to the spine, while passive electrodes were positioned 3 cm away. TENS therapy was utilized for 30 minutes in Group B, and the intensity of the pain and discomfort was adjusted to the patient's tolerance level.
Study NCT06545578 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: motor control exercises
Description: Training in coordinated trunk muscle action, including decreasing overactive superficial muscles and independent activation of deep muscles (such as transversus abdominis and multifidus). Exercises for the pelvic floor muscles, controlling respiration, and regulating the position and movement of the spine were added to these exercises.
Study NCT05482490 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Maintenance protocol for the hygiene of implant supported prosthesis
Description: Sequence of phases that include the hygiene and cleaning of the prosthesis and the implants, the motivation of the patients and reinforcement of oral hygiene.
Study NCT05046093 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Transbronchial cryobiopsy
Description: When the lung nodule is visualized by thin bronchoscope (4mm) with R-EBUS, cryobiopsy is performed. If not visualized, ultrathin (3mm) bronchoscope is used.~Cryobiopsy is performed with 1.1mm cryo-probe.
Study NCT05364034 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Urban Afforestation Intervention Program
Description: An afforestation intervention program based on land cultivation and transplantation of several plants for 90 minutes will be implemented.
Study NCT05167916 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Outpatient check cytoscopy
Description: Four weeks after primary TURBT, study participants will provide freshly voided urine sample which will be sent for cytology assessment by uropathologist in charge according to the Paris classification system. Suspicious sample for malignancy, low- and high-grade malignant samples will be considered positive results. On the other hand, hyperplastic or negative samples for malignancy will be defined as negative results.~Thereafter, patients will be assessed by flexible white light check cystoscopy under local anesthesia using flexible instrument by single operator. Checklist will be fulfilled by the operator urologist. Check cystoscopy will be considered positive when encountering residual gross lesion at the area of previous resection or newly developed lesions or both.
Study NCT05167916 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Urine cytology
Description: Four weeks after primary TURBT, study participants will provide freshly voided urine sample which will be sent for cytology assessment by uropathologist in charge according to the Paris classification system. Suspicious sample for malignancy, low- and high-grade malignant samples will be considered positive results. On the other hand, hyperplastic or negative samples for malignancy will be defined as negative results.~Thereafter, patients will be assessed by flexible white light check cystoscopy under local anesthesia using flexible instrument by single operator. Checklist will be fulfilled by the operator urologist. Check cystoscopy will be considered positive when encountering residual gross lesion at the area of previous resection or newly developed lesions or both.
Study NCT05360914 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hospital at Home (HaH) treatment
Description: The intervention is a new pathway of providing acut treatment for elderly acute ill patients in their own home. If the patient is randomized to the intervention group, the municipalities acute teams start the treatment. The acute team can take venous blood tests, ECG and bladder scan at home. The acute team handles the treatment at home and follows the patient closely. During the treatment course, the acute team and the ED specialist discuss the treatment process either over the phone or virtually on an iPad, where the patient is also involved. If the specialist would like to see the patient for assessment or send the patient for an X-ray, the specialist informs the acute team that the patient must go to a short check-up in the ED. Here, the specialist examines the patient himself and assesses whether the patient can continue to be treated at home, or whether the patient must be admitted to the hospital due to deterioration of the condition.
Study NCT05360914 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard hospital admission
Description: The active comparator is the standard hospital admission for elderly acute ill patients.
Study NCT04419766 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IR3535 (3-(N-acetyl-N-butyl) aminopropionic acid ethyl ester) house spraying
Description: The spraying will be performed monthly during the first 3 months, bimonthly during the next 6 months and then quarterly thereafter. The spraying will be carried out inside and outside the houses during the morning.
Study NCT05730348 — intervention group
Intervention type: BEHAVIORAL
Intervention: Post mealtime activity
Description: Therapist lead movement post meals
Study NCT06463379 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Solumedrol
Description: 2 days pulse steroid injection 125 mg methylrednisolone
Study NCT06463379 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Solumedrol
Description: 2 days pulse steroid injection 125 mg methylrednisolone
Study NCT06250179 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: free gingiva graft surgery
Description: For insufficient gingival height in patients, the free gingival graft taken from the palate will be sutured to the relevant area.
Study NCT06250179 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: free gingiva graft surgery
Description: For insufficient gingival height in patients, the free gingival graft taken from the palate will be sutured to the relevant area.
Study NCT04277767 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: observational
Description: No intervention
Study NCT05209646 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bee honey
Description: patients will receive honey for 8 weeks in a dose of 30 ml undiluted honey per day divided as 5 ml honey 30 minutes before each meal six times daily. The honey will be kept in a closed glass container and away from light until the time of use. Each patient will be provided with a well-sealed container containing 210 ml honey each week. The honey used in the study will be a raw, unprocessed Clover honey collected from AL Mahala-Gharbia governorate, Egypt. The honey will be supplied directly from a beekeeper without heating or gamma irradiation.
Study NCT06357026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous Ventricular Assist System（Phigine Medical）
Description: Percutaneous Ventricular Assist System or IABP provides intraoperative circulatory support during high-risk PCI.
Study NCT06357026 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: intra-aortic balloon pump (IABP)
Description: IABP provides intraoperative circulatory support during high-risk PCI.
Study NCT05431153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single dose of PF-07104091 as Tablet Formulation A (Treatment A)
Description: A single dose of PF-07104091 as Tablet Formulation A administered under fasting conditions.
Study NCT05431153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single dose of PF-07104091 as Tablet Formulation B (Treatment B)
Description: A single dose of PF-07104091 as Tablet Formulation B administered under fasting conditions.
Study NCT05431153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single dose of PF-07104091 as Tablet Formulation C (Treatment C)
Description: A single dose of PF-07104091 as Tablet Formulation C administered under fasting conditions.
Study NCT05431153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single dose of PF-07104091 as Tablet Formulation D (Treatment D)
Description: A single dose of PF-07104091 as Tablet Formulation D administered under fasting conditions.
Study NCT05431153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single dose of PF-07104091 as Tablet Formulation C (Treatment E)
Description: A single dose of PF-07104091 as Tablet Formulation C administered under fed conditions.
Study NCT04582396 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stellate ganglion block injection
Description: A stellate ganglion block (SGB) is an injection of local anesthetic (numbing medicine) to block the nerves located on either side of the voice box in the neck. It will be administered in an inpatient monitored setting.
Study NCT04582396 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline injection
Description: An injection of normal saline will be injected into muscle on either side of the voice box in the neck. It will be administered in an inpatient monitored setting.
Study NCT04582396 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Psychoeducation
Description: The session will be 30 minutes in duration, to be administered by a health professional with experience working with CA patients, the goal will be to establish rapport and help patient identify anxious situations, thoughts, and bodily feelings related their recent CA that could lead to avoidant behavior.~Explain how many of these feelings are common in CA survivors, and they are often unrelated to their risk of its recurrence. Explain how the body has a fight-or-flight system that is controlled in part by the stellate ganglion and explain how blocking the action of this part of the body can reduce the feelings of anxiety that commonly occur. Discuss how certain activities such as exercise can increase feelings of anxiety around bodily sensations, but continued engagement could reduce that fear and that exercise is helpful for recovering from CA
Study NCT04582396 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: The session will be 30 minutes in duration, to be administered by a health professional with experience working with CA patients, the goal will be to establish rapport and help patient identify anxious situations, thoughts, and bodily feelings related their recent CA that could lead to avoidant behavior.~Explain how many of these feelings are common in CA survivors, and they are often unrelated to their risk of its recurrence. Explain how the body has a fight-or-flight system that is controlled in part by the stellate ganglion and explain how blocking the action of this part of the body can reduce the feelings of anxiety that commonly occur. Discuss how certain activities such as exercise can increase feelings of anxiety around bodily sensations, but continued engagement could reduce that fear and that exercise is helpful for recovering from CA
Study NCT06227065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: In PDOs from patients that show highest response to Epirubicin, this drug will be instilled intravesically once weekly for 6 times.~Epirubicin will be used as a concentrate for injection/instillation 2 mg/ml in total 50mg per vial. Prior to use, the concentrate for injection is diluted with 25ml of 0.9% saline solution to obtain the final Solution with 1mg/ml of Epirubicin.
Study NCT05447910 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood and tissue samples
Study NCT05447910 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Given PO
Study NCT05553535 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: retrospective review of shoulder MRI
Study NCT04958291 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-99677
Description: CC-99677
Study NCT04958291 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo
Study NCT06307067 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Urine dipstick
Description: Urine dipstick is a point of care test that can be performed on the urine in the public health center.
Study NCT05131932 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic ablation of inlet patch
Description: Endoscopic ablation of inlet patch using argon plasma coagulation (APC)
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Motor Tests
Description: To assess motor function annually
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Motor Tests
Description: To assess motor function annually
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cognitive Tests
Description: To assess cognitive function annually
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cognitive Tests
Description: To assess cognitive function annually
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Unenhanced-MRI of the brain
Description: The UE-MRI of the brain will be performed at baseline and at the year 5 visit in order to exclude presence of a significant MRI abnormality
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Unenhanced-MRI of the brain
Description: The UE-MRI of the brain will be performed at baseline and at the year 5 visit in order to exclude presence of a significant MRI abnormality
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gadolinium Measurements
Description: Blood samples and spontaneous urine specimens will be collected through the course of the study to measure Gd concentration
Study NCT04373564 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Gadolinium Measurements
Description: Blood samples and spontaneous urine specimens will be collected through the course of the study to measure Gd concentration
Study NCT04800783 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Swallowing ultrasound
Description: Ultrasound assessment of the tongue movement and thickening, the geniohyoid and suprahyoid muscles echogenicity, thickness and thickening, the hyoid bone elevation, and the number of swallowing trial.
Study NCT04373564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoxetate disodium
Description: Administered as defined by the treating physician as part of routine clinical practice
Study NCT04373564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine
Description: Administered as defined by the treating physician as part of routine clinical practice
Study NCT04373564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadodiamide
Description: Administered as defined by the treating physician as part of routine clinical practice
Study NCT04373564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoterate meglumine
Description: Administered as defined by the treating physician as part of routine clinical practice
Study NCT04373564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadobutrol
Description: Administered as defined by the treating physician as part of routine clinical practice
Study NCT04373564 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoteridol
Description: Administered as defined by the treating physician as part of routine clinical practice
Study NCT05376904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR18034
Description: HR18034 low dose
Study NCT05376904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR18034
Description: HR18034 midium dose
Study NCT05376904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HR18034
Description: HR18034 high dose
Study NCT05376904 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ropivacaine HCl.
Description: ropivacaine HCl.
Study NCT05718141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: COMET-GB
Description: Online self-guided single session intervention - comprised of 4 modules based on the core principles of CBT, combined with principles from positive psychology. Each module includes short reading exercises, informational videos, and writing exercises.~* Cognitive Restructuring (labelled Flexible Thinking)~* Behavioural Activation (labelled Positive Activities)~* Gratitude~* Self-Compassion~The initial intervention modules and assessment will take participants approximately 60-75 minutes to complete (15-20 minutes for the assessment measures only).
Study NCT05559944 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expressive Writing
Description: Participants will be asked to write about the biggest body image or eating-related stressor they have experienced as a member of the LGBTQ+ community.
Study NCT05559944 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Affirmation
Description: Participants will receive one new vignette per day describing a SM young adult experiencing severe body image stress in Alabama. Participants will be asked to write to this person and provide advice based on their own experience as a SM young adult. Vignettes will be identical across participants; however, they will be matched to participants' sexual identity, gender identity, and race/ethnicity.
Study NCT05559944 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: Consistent with prior research participants will write about their routine daily activities since waking up for 20 minutes each day, sans emotional content.
Study NCT06386900 — intervention group
Intervention type: OTHER
Intervention: Cyclist
Description: Participating in the Grand Tour as cyclist
Study NCT05692804 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Mini Mental State Examination(MMSE),Montreal Cognitive Assessment ( MoCA),S100B ( protein S100 subunit beta) ,GFAP ( glial fibrillary acidic protein ),NSE ( neuron-specific enolase )
Description: MMSE and MoCA will be applied preoperative,postoperative first day and fourth day S100B,GFAP and NSE will be measured in blood tests preoperative,postoperative second hour,postoperative 24. hour and postoperative 96. hour
Study NCT06210815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HLX42
Description: HLX42 is an anti-EGFR monoclonal antibody conjugated with a novel high potency DNA topoisomerase I (topo I) inhibitor, with a drug-antibody-ratio (DAR) of 8.
Study NCT05427747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cefotaxime
Description: One group will be given cefotaxime and another group meropenem.~The efficacy of antibiotic therapy will be checked with:~* Follow-up paracentesis after 48 hours of initiation of empiric antibiotic treatment showing reduction in neutrophil count of at least 25% .~* Decrease of peritoneal fluid PMN count to \< 250 cells/μ at end of treatment and negative previously positive ascitic fluid culture.
Study NCT04769739 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CO2
Description: using CO2 insufflation to help insertion
Study NCT04769739 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Water
Description: using water instead of traditional gas to help insertion
Study NCT04769739 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 50% saline
Description: using 50% saline solution instead of traditional gas to help insertion
Study NCT04769739 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 25% saline
Description: using 25% saline solution instead of traditional gas to help insertion